Schrodinger Cash Flow Statement
NASDAQ: SDGRHealthcareHealth Information ServicesUSD
27.28+0.89 (+3.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Schrodinger free cash flow
In fiscal 2025, Schrodinger generated $13.9 million of operating cash flow and spent $1.4 million on capital expenditures. That left free cash flow of $12.5 million, a free-cash-flow margin of 4.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Schrodinger cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -103.27M | -187.12M | 40.72M | -149.19M | -101.22M | -26.64M | -25.68M |
| Net Income growth (YoY) | — | -559.54% | — | — | — | — | — |
| Depreciation & Amortization | 6.02M | 6.16M | 5.55M | 4.34M | 2.85M | 3.66M | 3.64M |
| Stock-Based Compensation | 43.00M | 49.90M | 47.84M | 39.63M | 26.49M | 10.54M | 2.19M |
| Change in Working Capital | 122.09M | -23.82M | -29.44M | -31.49M | -2.88M | 52.03M | 1.79M |
| Operating Cash Flow | 13.90M | -157.37M | -136.73M | -119.68M | -70.67M | 16.76M | -26.06M |
| Capital Expenditures | -1.44M | -7.31M | -13.40M | -8.01M | -7.17M | -2.54M | -1.84M |
| Investing Cash Flow | 57.90M | 148.84M | 193.03M | 90.02M | -16.81M | -381.72M | -53.85M |
| Financing Cash Flow | 2.93M | 10.12M | 9.05M | 2.11M | 7.95M | 541.27M | 28.68M |
| Net Change in Cash | 74.73M | 1.59M | 65.35M | -27.55M | -79.53M | 176.31M | -51.23M |
| Free Cash Flow | 12.46M | -164.68M | -150.14M | -127.70M | -77.84M | 14.22M | -27.89M |
This table shows 7 annual periods of Schrodinger's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SDGR's reporting calendar. What is a cash flow statement?